drugset / Trial / NCT00916253

Method of Assessment of Driving Ability in Patients Suffering From Wakefulness Pathologies

NCT00916253

Completed 27 enrolled University Hospital, Bordeaux
RandomizedCrossoverDouble-blindDiagnostic

Summary

The project will improve scientific knowledge regarding a recent law applying potentially to every french driver. It will give for the first time an indication on the impact of alerting treatments on driving risks. It will reinforce the links between different research environments (sleep physiopathology, clinical research, cognitive neurosciences, driver's supervision, virtual reality, pharmacology) among the RESAT network (Réseau Eveil Sommeil Attention Transport). It will stimulate data acquisition in technological research to better understand the difference between real and simulated driving

Timeline

Start
2010-03
Primary completion
2012-07
Completion
2012-08

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Modafinil Small molecule 400 mg

Indications